The Emerging TNNT3 Spectrum: From Distal Arthrogryposis to Congenital Myopathy.

Nami Altin, Kamel Mamchaoui, Jessica Ohana, Anne Bigot, Beatrice Corradi, Luca Maragliano, Francesca Madia, Marzia Ognibene, Mohammad Sadegh Shams Nosrati, Dario Paladini, Michele Iacomino, Asma Rashid, Olaf Bodamer, Susana Quijano-Roy, Jaya Punetha, Valeria Capra, Federico Zara, Capucine Trollet, Marcello Scala

Journal: Human mutation 2025;2025():1785045

PMID: 41473596

Abstract

Distal arthrogryposis (DA) is a group of nonprogressive congenital muscular disorders affecting distal limb joints, without concurrent neuromuscular disease. Ten different types of DAs are known, with many different genes involved. Dominant variants in TNNT3 (MIM ∗600692) cause DA type 2B2 (MIM #618435), a severe condition featuring dysmorphism, distal contractures, and deformities of hands and feet. TNNT3 encodes the fast skeletal troponin T, an essential component of the troponin complex that is necessary for calcium-coupled contraction initiation in the striated muscle. Recently, homozygous splicing variants in TNNT3 have been reported in two subjects with a distinctive congenital myopathy, only partially overlapping DA2B2. However, no functional evidence was provided. In this study, we investigated two patients presenting with myopathic conditions at different ends of the TNNT3 spectrum. One subject showed DA, whereas the second displayed a severe congenital myopathy featuring hypotonia, DA, and dysmorphism. Through exome sequencing, we identified the de novo missense change p.(Arg63His) in Subject #1 and biallelic TNNT3 variants in Subject #2, featuring a splicing and a stop gain variant. The p.(Arg63His) was predicted to affect the stability of troponin T3 in silico, and we confirmed this by western blot. Then, employing different biochemical approaches, we showed that the truncated variants identified in #2 (p.[Tyr13∗] and c.480+5G>A) lead to loss of the full-length protein. Our findings refine and expand the TNNT3 genotype-phenotype spectrum, suggesting that recessive TNNT3-related congenital myopathy should be considered a discrete entity caused by biallelic loss-of-function variants.

Copyright © 2025 Nami Altin et al. Human Mutation published by John Wiley & Sons Ltd.

Address: Sorbonne Université, INSERM, Institute of Myology, Centre of Research in Myology, Paris, France, sorbonne-universites.fr.; Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genoa, Italy, iit.it.; Department of Experimental Medicine, University of Genova, Genoa, Italy, unige.it.; Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genoa, Italy, iit.it.; Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy, univpm.it.; Medical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy, gaslini.org.; Medical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy, gaslini.org.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università Degli Studi di Genova, Genoa, Italy, unige.it.; Fetal Medicine and Surgery Unit, Department Mother and Child, IRCCS Istituto Giannina Gaslini, Genoa, Italy, gaslini.org.; Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, USA, harvard.edu.; Garches Neuromuscular Reference Center, Child Neurology and ICU Department, APHP Raymond Poincare University Hospital (UVSQ Paris Saclay), Garches, France.; GeneDx, Gaithersburg, Maryland, USA, genedx.com.; Clinical Genomics and Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy, gaslini.org.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.